Uploads
Contact
/
Login
Upload
Search Results for 'Clinical Biosimilars'
Application of Biosimilars in RA IN Clinical Practice:
conchita-marotz
Biosimilars
lindy-dunigan
Biosimilars in emerging markets- regulatory and Commercial considerations
jane-oiler
Biosimilars in RA: A Blessing or a Curse?
conchita-marotz
Biosimilars & EU regulation
karlyn-bohler
Biological Products: concepts, naming,
faustina-dinatale
PhAMA Position on Biosimilar Medicines
celsa-spraggs
Acceptable changes in quality attributes of glycosylated bi
debby-jeon
ASBM Biosimilars US Prescribers and Biosimilars Naming
min-jolicoeur
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
calandra-battersby
Biosimilars in the Real World
liane-varnes
Biosimilars are effective and safe and should immediately replace innovator molecules
myesha-ticknor
Understanding Biologics Biologics and Biosimilars
calandra-battersby
Applying Biosimilars in Hematologic Cancers
conchita-marotz
US Regulatory Pathway For Biosimilars
cheryl-pisano
Latin American Biologics/Biosimilars Conference
giovanna-bartolotta
Faculty Leonard H. Calabrese, DO
trish-goza
ASBM Biosimilars
phoebe-click
Bio similars A Presentation
kittie-lecroy
Biosimilars Guideline – a Summary of the Industry Comments
marina-yarberry
Comparison of US/EU Biosimilar
aaron
Comparison of US/EU Biosimilar
danika-pritchard
Comparison of US/EU Biosimilar
myesha-ticknor
A QUM partnership approach to regulating
liane-varnes
1
2
3
4
5
6